Trial of IIb Preserving Neck Dissection
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
The treatment of clinically N0 neck in malignancies of oral cavity is controversial. The options include the policy of "wait and watch"(close observation and follow-up), elective irradiation of the neck, elective surgery of the neck (neck dissection).
In elective neck dissections, the procedures commonly performed are modified radical neck dissection-III (functional neck dissection) and selective (supraomohyoid) neck dissection depending on the site of the primary lesion within the oral cavity. There are no trials of IIb preserving neck dissection in cancers of the oral cavity.
Condition | Intervention | Phase |
---|---|---|
Oral Cancer |
Procedure: Selective neck dissection Procedure: Conventional Neck dissection |
Phase 3 |
Study Type: | Interventional |
Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
Official Title: | Randomized Controlled Trial of IIb Preserving Neck Dissection VS Neck Dissections Involving IIb Removal (Selective/Functional) in Patients With N0 Neck With Oral Cavity Malignancies |
- Spinal accessary nerve function [ Time Frame: 2 years ] [ Designated as safety issue: No ]
- neck Node failure [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]
Estimated Enrollment: | 100 |
Study Start Date: | August 2007 |
Estimated Primary Completion Date: | September 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Experimental: 1
IIb preserving neck dissection
|
Procedure: Selective neck dissection
Level IIb preserving neck dissection
|
2
Conventional neck dissection
|
Procedure: Conventional Neck dissection
Conventional neck dissection (MRND type III or Supraomohyoid)
|
Detailed Description:
Surgery of the cervical lymphatic system has evolved a lot since the introduction of classical radical neck dissection by Crile in 1906, which was later established by Martin (1945). It includes the removal of cervical lymphatic levels I-V along with removal of non-lymphatic structures namely submandibular gland, tail of parotid, omohyoid muscle, cervical plexus of nerves, spinal accessory nerve, internal jugular vein and sternocleidomastoid muscle. The main morbidity of the radical neck dissection was the trapezius muscle dysfunction with shoulder drop, resulting in pain and shoulder dysfunction. The other morbidities of radical neck dissection were cosmetic deformity of neck, painful neuromas, increased facial swelling, numbness of neck and ear.
In the last three decades, many modifications of the classical radical neck dissection (modified radical neck dissections), had been described and are increasingly applied. The main modifications have been the preservation of one or more of the non-lymphatic structures that were removed in classical radical neck dissection mainly the spinal accessory nerve, internal jugular vein, sternocleidomastoid muscle (Bocca and Pignataro, 1967). The reasons for developing these modifications were functional and cosmetic, while preserving the oncological safety of the procedure.
Much later in 1980s, the concept of selective neck dissection, for which Lindberg (1972) and Skolnik (1976) laid down important basis, was introduced. In selective neck dissections only those groups of lymph nodes are removed, which, depending upon the location of the primary tumour, are most likely to contain metastasis (Shah, 1990).
The first selective neck dissection introduced was the supraomohyoid neck dissection, which includes the removal of lymph node levels I-III, while preserving the non-lymphatic structures as functional neck dissection. Medina and Byers in a prospective study have demonstrated the utility of this supraomohyoid neck dissection in patients with clinically negative neck nodes (N0) with malignancies of oral cavity.
The posterolateral neck dissection removes lymph node levels II-V as well as retroauricular and suboccipital nodes, which is used primarily for treatment of tumours of scalp and post auricular skin.
The lateral neck dissection, which includes removal of lymph node levels II-IV, is done for tumours of larynx or hypopharynx with N0 neck.
The anterior compartment neck dissection includes removal of only lymph node level VI which is done in thyroid malignancies when there is no evidence of lateral lymphadenopathy, and is combined with lateral neck dissection(anterolateral) if there are lymphnodes involved.
Recently the concept of superselective neck dissections has been introduced. It is less radical than selective neck dissections, removing lesser number of at-risk lymph nodal groups.
H Coskun (2004) found IIb preserving superselective neck dissection as oncologically safe procedure in N0 laryngeal cancer, with more functional preservation of trapezius muscle and hence negligible shoulder disability. In this study, it was found that even in selective neck dissection, some degree of spinal accessory nerve dysfunction and shoulder disability occurs as a result of retraction of the nerve during the clearance of the lymph nodes posterior and superior to the nerve (IIb). If these lymph nodes were not removed and left in place, there would be no stretching of spinal accessory nerve during the neck dissection and shoulder disability could be avoided
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients >18yrs of age.
- histologically proven squamous cell carcinoma
- clinical and radiological N0 neck
Exclusion Criteria:
Pregnant and lactating women
- Patients with synchronous primaries
- H/o previous malignancy except BCC
Previous surgeries on neck
- Post radiotherapy recurrence.
Contact: Manoj Pandey, MS | +91-542-2309511 | manojpandey@vsnl.com |
India | |
Banaras Hindu University | Recruiting |
Varanasi, UP, India, 221005 | |
Contact: Manoj Pandey, MS +91-542-2309511 manojpandey@vsnl.com | |
Principal Investigator: Manoj Pandey, MS | |
Sub-Investigator: Deepika Joshi, MD, DM | |
Sub-Investigator: Mohan Kumar, MD |
Principal Investigator: | Manoj Pandey, MS | Banaras Hindu University |
Publications:
Responsible Party: | Dr. Manoj Pandey, Head, Banaras Hindu University |
ClinicalTrials.gov Identifier: | NCT00847717 History of Changes |
Other Study ID Numbers: | SND_01 |
Study First Received: | February 18, 2009 |
Last Updated: | August 10, 2009 |
Health Authority: | India: Institutional Review Board |
Keywords provided by Banaras Hindu University:
Oral cancer surgery neck dissection spinal accessory nerve |
Additional relevant MeSH terms:
Mouth Neoplasms Head and Neck Neoplasms Neoplasms by Site |
Neoplasms Mouth Diseases Stomatognathic Diseases |
ClinicalTrials.gov processed this record on September 26, 2012